Fig. 8From: CXCL12 expression promotes esophageal squamous cell carcinoma proliferation and worsens the prognosisIn vivo proliferation assay; TE4CXCL12+ with or without infusion of AMD3100. TE4CXCL12+ mice continuously infused with AMD3100 showed smaller tumors than control mice at all time points. AMD3100 significantly decreases the tumor size on day 14 (p = 0.03)Back to article page